Industry Experts

Carter leads Kemp's scientific and technology teams, bringing over 20 years of expertise in protein chemistry and structural biology. With a Ph.D. in Structural Biology, Carter has extensive experience in isolating and characterizing complex proteins, spanning both recombinant and natural sources. He previously developed a drug discovery pipeline based on mammalian microbiomes, which led him to the National Cancer Institute, where he earned the Director’s Innovation Award for his work with bioactive proteins from marine aqueous extracts. Prior to Kemp, Carter served as Chief Technology Officer and Director of Structural Biology at a biotech start-up, where he built and developed a protein expression and isolation laboratory, overseeing the protein production and purification team. At Kemp, he is advancing high-throughput workflows by implementing machine learning routines to streamline protein design and characterization, enhancing speed, accuracy, and reproducibility. His efforts align with Kemp's goals of pushing the boundaries of what is possible in protein science, ultimately supporting more advanced and efficient biotechnological solutions.